具有前所未有的选择性的5-HT2C受体的亚泽胺激剂:发现贝克西沙林 (LP352)
Albert Ren1, Xiuwen Zhu1, Juerg Lehmann1
1Arena Pharmaceuticals, 6154 Nancy Ridge Drive, San Diego, California 92121, United States.
新的5-HT2C受体疗法显示出有前途. 一种新的化合物,贝克西沙林,显示出高选择性和改善的药理动力学,进步到临床开发潜在的治疗应用.
科学领域:
- 药用化学 医学化学
- 神经药理学神经药理学
- 药物发现 药物发现 药物发现
背景情况:
- 5-HT2CR疗法的临床开发受到选择性和目标之外的担忧的阻碍.
- 为了解决这些局限性,正在探索新的二胺基基架.
研究的目的:
- 设计和合成具有对5-HT2CR.R.高选择性的新化合物.
- 为了优化临床开发的药理动力学特性.
主要方法:
- 将二次胺基替代物引入6,5,7三环二胺基架.
- 功能和结合测试以评估受体选择性.
- 在体内药理动力学研究以评估半衰期,生物可用性和清除.
- 在老鼠再养模型中评估体内疗效.
主要成果:
- 确定了一系列具有前所未有的5-HT2CR选择性的新型化合物.
- 化合物19m (贝克西沙林) 呈现出极好的口服生物可用性,中枢神经系统透,以及降低干净度.
- (+) -19m在体内表现出强大的点效应以及对相关受体的高选择性 (5-HT2AR,5-HT2BR).
结论:
- 开发的6,5,7-三环二胺基架产生高度选择性的5-HT2CR配体.
- 优化的化合物19m (bexicaserin) 具有有利的类似药物的特性,并已进入临床试验.
更多相关视频
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antipsychotic Drugs: Typical and Atypical Agents
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Antidepressant Drugs: MAOIs and Other Agents
